| ETEST IMIPENEM RELEBACTAM. in vitro diagnosticZ-2226-2021 · JWY | Biomerieux Inc | Recall | Aug 6, 2021FDA record creation date |
| VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL)K201675 · LON | bioMerieux, Inc. | 510(k) | Jul 9, 2021FDA decision date |
| VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML)K211136 · LON | bioMerieux, Inc. | 510(k) | Jun 14, 2021FDA decision date |
| VIDAS CMV IgM 30 TestsZ-1408-2021 · LKQ | Biomerieux Inc | Recall | Apr 10, 2021FDA record creation date |
| VITEK 2 (version numbers 8.01, 8.02 (8.0x) and 9.01, 9.02 (9.0x) with the external communication configured to HL7 (system, test, automated, anti…Z-1307-2021 · LON | Biomerieux Inc | Recall | Mar 25, 2021FDA record creation date |
| VITEK 2 Compact (version numbers 8.01, 8.02 (8.0x) and 9.01, 9.02 (9.0x) with the external communication configured to HL7 (system, test, automat…Z-1308-2021 · LON | Biomerieux Inc | Recall | Mar 25, 2021FDA record creation date |
| VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL)K193299 · LON | bioMerieux, Inc. | 510(k) | Sep 28, 2020FDA decision date |
| VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL)K200590 · LON | bioMerieux, Inc. | 510(k) | Apr 28, 2020FDA decision date |
| PREVI Isola Insrument and PREVI Isola Printer spares PSUs (power supply units), P1028888-001 PSU (used in Zebra LP2824 Plus printers)
PSUs wit…Z-1793-2020 | bioMerieux, Inc. | Recall | Apr 23, 2020FDA record creation date |
| The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determ…Z-1742-2020 · N/A | Biomerieux Inc | Recall | Apr 17, 2020FDA record creation date |
| VITEK 2 card AST-N371 - Product Usage: The VITEK 2 is an automated system consisting of instruments, software, and reagent cards designed for the…Z-1534-2020 · N/A | bioMerieux, Inc. | Recall | Mar 20, 2020FDA record creation date |
| VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL)K193572 · LON | bioMerieux, Inc. | 510(k) | Mar 13, 2020FDA decision date |
| BIOMERIEUX VIDAS 3, Compact immunoanalyzer with full traceability and automationZ-0928-2020 · JJE | Biomerieux Inc | Recall | Mar 2, 2020FDA record creation date |
| VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 >=16 ug/mL)K193567 · LON | bioMerieux, Inc. | 510(k) | Feb 14, 2020FDA decision date |
| VIDAS Varicella Zoster IgG (VZG) antibody IVD, kitZ-1107-2020 · LFY | bioMerieux, Inc. | Recall | Feb 7, 2020FDA record creation date |
| Vitek DensichekK192110 · LON | bioMerieux, Inc. | 510(k) | Oct 31, 2019FDA decision date |
| VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL)K191766 · LON | bioMerieux, Inc. | 510(k) | Aug 5, 2019FDA decision date |
| VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL)K190616 · LON | bioMerieux, Inc. | 510(k) | Jun 6, 2019FDA decision date |
| BACT/ALERT MP Reagent SystemK190405 · MDB | bioMerieux, Inc. | 510(k) | May 15, 2019FDA decision date |
| Biomerieux Vitek 2 Test kit
VITEK 2 is an automated system consisting of instruments, software and reagent cards designed for the identificatio…Z-1137-2019 · LON | bioMerieux, Inc. | Recall | Apr 12, 2019FDA record creation date |
| VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL)K183524 · LON | bioMerieux, Inc. | 510(k) | Mar 12, 2019FDA decision date |
| VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL)K183551 · LON | bioMerieux, Inc. | 510(k) | Mar 7, 2019FDA decision date |
| VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 >=64/8 µg/mL)K183360 · LON | bioMerieux, Inc. | 510(k) | Feb 26, 2019FDA decision date |
| VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL)K183415 · LON | bioMerieux, Inc. | 510(k) | Feb 20, 2019FDA decision date |
| VITEK 2 AST-N351 Test KitZ-0847-2019 · LON | bioMerieux, Inc. | Recall | Feb 16, 2019FDA record creation date |